Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 407-920-5 | CAS number: 6390-69-8 CA 16-178
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study (GLP)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- May 26, 1983
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol
- EC Number:
- 407-920-5
- EC Name:
- 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol
- Cas Number:
- 6390-69-8
- Molecular formula:
- C28 H42 O2
- IUPAC Name:
- 3,3',5,5'-tetra-tert-butyl-[1,1'-biphenyl]-2,2'-diol
- Details on test material:
- - Name of test material (as cited in study report): generic name CA 16-178
- Analytical purity: 97.7% (not specified in the study [Lab. sample], transfered from 28d study [BASF SE [Ciba-Geigy Ltd/884619]], with same Lot/batch)
- Lot/batch No.: A 88103 / Z 1572R
- Storage condition of test material: room temperature
- Stability under test conditions: ensured by sponsor
- Other: gloves and face masks as safety precautions
Constituent 1
Test animals
- Species:
- hamster
- Strain:
- other:
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: chinese hamster (Cricetulus griseus) random outbred strain from Ciba-Geigy Tierfarm, Sisseln, Switzerland
- Weight at study initiation: females 25-32 g, males 28-35 g (tolerability test); females 24-35 g, males 25-35 g (mutagenicity test)
- Assigned to test groups randomly: yes
- Housing: individual caging
- Diet (e.g. ad libitum): standard diet: NAFAG No.924; ad libitum
- Water (e.g. ad libitum): tap water; ad libitum
- Acclimation period: at least 3 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-24°C (1°C above the range described in the protocol)
- Humidity (%): 44-49%
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: CMC (carboxymethyl cellulose); 0.5% aqueous solution
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The highest applicable dose was 5000 mg/kg bw (solubility limit) - Duration of treatment / exposure:
- one single treatment
- Frequency of treatment:
- once
- Post exposure period:
- sampling was performed 16, 24 or 48 hours after treatment
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
5000 mg/kg bw
Basis:
actual ingested
in the mutagenicity main test
- Remarks:
- Doses / Concentrations:
200, 1000 and 5000 mg/kg bw
Basis:
actual ingested
in the tolerability pretest
- No. of animals per sex per dose:
- 2 (pretest) or 8 (per group and per sampling time; main test)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: oral
- Doses / concentrations: 64 mg/kg in 20 ml/kg CMC 0.5%, sacrificed after 24 hours
Examinations
- Tissues and cell types examined:
- Bone marrow / bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
After pre-test treatment for determination of tolerability of the test substance, the treated animals were observed for a period corresponding to the interval between administration and sacrifice of the animals in the main test, plus one day. Depending on the outcome the highest dose causing no death is used as the highest in the main test, or if necessary the test is repeated with lower doses. In this experiment, the dose of 5000 mg/kg was determined as the highest applicable in the main assay.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
16, 24 or 48 hours after treatment, the animals were sacrificed by dislocation of the cervical vertebrae.
DETAILS OF SLIDE PREPARATION:
Bone marrow is harvested from the shafts of both femurs with fetal calf serum. After centrifugation small drops of the sediment mixture are transferred on the end of a slide, spread out with the aid of a polished cover glass and the preparations are air-dried. Within 24 hours, the slides are stained in undiluted May-Gruenwald solution for 3 min then in May-Gruenwald solution/water 1/1 for 2 min. After being rinsed in distilled water, the slides are left immersed in diluted Giemsa solution (16.6%), for 10 min. After rinsing with distilled water and air-drying, the slides are cleared in Xylene and mounted.
METHOD OF ANALYSIS:
The slides were coded prior to analysis and the quality of staining evaluated. The slides of five animals from each sex showing the best differentiation between mature and polychromatic erythrocytes were selected for later scoring. The slides of five female and five male animals per dose group (negative control group, dosage group and positive control group) were examined at scheduled sampling time.
1000 polychromatic erythrocytes per animal each are scored for the incidence of micronuclei. To determine the mitotic activity of the red compartment, the ratio of polychromatic to normochromatic erythrocytes is calculated for each animal by counting a total of 1000 erythrocytes. A low proportion of polychromatic erythrocytes is indicative for a mitose inhibiting activity of the test substance. - Evaluation criteria:
- The significance of difference is assessed by X2-test.
- Statistics:
- - A test substance is considered to be active in this test system if a statistically significant increase in the number of polychromatic erythrocytes with micronuclei in comparison with the negative control occurs at any sampling time.
- Assay acceptance criteria:
(1) the quality of the slides must allow a clear differentiation between polychromatic and normochromatic erythrocytes;
(2) the result obtained with the positive control has to fulfill the criteria given for a positive response;
(3) both the negative and the positive control are within range of the available historical negative and positive control data (mean control data from the studies performed within one year available).
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Remarks:
- no significant increase in the number of micronucleated polychromatic erythrocytes compared to the vehicle treated animals
- Toxicity:
- no effects
- Remarks:
- but evaluated above the limit dose (at 5000 mg/kg bw)
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
In the tolerability test the highest applicable dose of 5000 mg/kg (as well as the mid and low doses) caused no death in a group of four animals. Therefore, this dose was taken as the highest in the mutagenicity test.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): there was no significant increase in the number of micronucleated polychromatic erythrocytes in the animals treated with the dose of 5000 mg/kg of test substance as compared with the negative control animals at all three sampling times. By contrast, the positive control yielded a marked increase of the percentage of micronucleated cells. Here the mean percentage of polychromatic erythrocytes with micronuclei was 1.82. In comparison with the negative control (0.03) this value was highly significant (p<0.05).
- Ratio of PCE/NCE (for Micronucleus assay): no significant changes compared to negative control values
Any other information on results incl. tables
Table 1: Summary of number of polychromatic erythrocytes with micronuclei and ratio of polychromatic to normochromatic (PCE/NCE) erythrocytes (arithmetic mean per sex and group).
Sampling time (hours) |
Sex |
Number of polychromatic erythrocytes |
Number of Normochromatic erythrocytes |
Ratio of PCE/NCE |
Number of polychromatic erythrocytes with micronuclei |
% of poly-chromatic erythrocytes with micronuclei |
Negative control (0.5% CMC) |
||||||
16 |
Males |
560 |
440 |
1.3 |
1.2 |
0.12 |
Females |
493 |
507 |
1 |
0.2 |
0.02 |
|
24 |
Males |
455 |
545 |
0.8 |
0.4 |
0.04 |
Females |
447 |
553 |
0.8 |
0.2 |
0.02 |
|
48 |
Males |
450 |
550 |
0.8 |
0.6 |
0.06 |
Females |
476 |
524 |
0.9 |
0.2 |
0.02 |
|
Test substance (5000 mg test substance/kg bw) |
||||||
16 |
Males |
539 |
461 |
1.2 |
0.2 |
0.02 |
Females |
533 |
467 |
1.1 |
0.2 |
0.02 |
|
24 |
Males |
494 |
506 |
1 |
0.4 |
0.04 |
Females |
465 |
535 |
0.9 |
0 |
0 |
|
48 |
Males |
519 |
481 |
1.1 |
0 |
0 |
Females |
530 |
470 |
1.1 |
0 |
0 |
|
Positive control (64 mg cyclophosphamide/kg bw) |
||||||
24 |
Males |
415 |
585 |
0.7 |
24 |
2.4 |
Females |
422 |
578 |
0.7 |
12.4 |
1.24 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.